These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3008062)

  • 1. Intrathecal D-Ala2-D-Leu5-enkephalin (DADL) restores analgesia in a patient analgetically tolerant to intrathecal morphine sulfate.
    Krames ES; Wilkie DJ; Gershow J
    Pain; 1986 Feb; 24(2):205-209. PubMed ID: 3008062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance and cross tolerance to morphine after chronic spinal D-Ala2-D-Leu5-enkephalin infusion.
    Tseng LF
    Life Sci; 1982 Sep; 31(10):987-92. PubMed ID: 6752616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial cross tolerance to D-Ala2-D-Leu5-enkephalin after chronic spinal morphine infusion.
    Tseng LF
    Life Sci; 1983 May; 32(22):2545-50. PubMed ID: 6304439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The analgesic efficacy of intrathecal D-Ala2-D-Leu5-enkephalin in cancer patients with chronic pain.
    Moulin DE; Max MB; Kaiko RF; Inturrisi CE; Maggard J; Yaksh TL; Foley KM
    Pain; 1985 Nov; 23(3):213-221. PubMed ID: 3906516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine-like discriminative stimulus effects of opioid peptides: possible modulatory role of D-Ala2-D-Leu5-enkephalin (DADL) and dynorphin A (1-13).
    Ukai M; Holtzman SG
    Psychopharmacology (Berl); 1988; 94(1):32-7. PubMed ID: 2894701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid pharmacokinetics of intrathecal morphine sulfate and D-Ala2-D-Leu5-enkephalin.
    Moulin DE; Inturrisi CE; Foley KM
    Ann Neurol; 1986 Aug; 20(2):218-22. PubMed ID: 3530119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on spinal opiate receptor pharmacology. III. Analgetic effects of enkephalin dimers as measured by cutaneous-thermal and visceral-chemical evoked responses.
    Schmauss C; Shimohigashi Y; Jensen TS; Rodbard D; Yaksh TL
    Brain Res; 1985 Jul; 337(2):209-15. PubMed ID: 2992678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse.
    Porreca F; Heyman JS; Mosberg HI; Omnaas JR; Vaught JL
    J Pharmacol Exp Ther; 1987 May; 241(2):393-400. PubMed ID: 3033214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo evidence for multiple opiate receptors mediating analgesia in the rat spinal cord.
    Tung AS; Yaksh TL
    Brain Res; 1982 Sep; 247(1):75-83. PubMed ID: 6127147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of opioid peptides on respiration and analgesia in rats.
    Flórez J; Pazos A
    Life Sci; 1982 Sep 20-27; 31(12-13):1275-7. PubMed ID: 6292613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opiate binding in calf thalamic membranes: a selective mu 1 binding assay.
    Clark JA; Houghten R; Pasternak GW
    Mol Pharmacol; 1988 Sep; 34(3):308-17. PubMed ID: 2901663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal delta-receptor ligand produces analgesia in man.
    Onofrio BM; Yaksh TL
    Lancet; 1983 Jun; 1(8338):1386-7. PubMed ID: 6134164
    [No Abstract]   [Full Text] [Related]  

  • 13. Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates.
    Fang FG; Fields HL; Lee NM
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1039-44. PubMed ID: 3018217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous intrathecal opioid analgesia: tolerance and cross-tolerance of mu and delta spinal opioid receptors.
    Russell RD; Leslie JB; Su YF; Watkins WD; Chang KJ
    J Pharmacol Exp Ther; 1987 Jan; 240(1):150-8. PubMed ID: 3027302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of analgesic potencies of mu, delta and kappa agonists locally applied to various CNS regions relevant to analgesia in rats.
    Satoh M; Kubota A; Iwama T; Wada T; Yasui M; Fujibayashi K; Takagi H
    Life Sci; 1983; 33 Suppl 1():689-92. PubMed ID: 6141508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternated delta and mu receptor activation: a stratagem for limiting opioid tolerance.
    Russell RD; Kwen-Jen C
    Pain; 1989 Mar; 36(3):381-389. PubMed ID: 2540475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
    Ward SJ; Takemori AE
    J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the effects of intrathalamically injected DADL and morphine on nociceptive thresholds and electroencephalographic activity: a thalamic delta receptor syndrome.
    Walker GE; Yaksh TL
    Brain Res; 1986 Sep; 383(1-2):1-14. PubMed ID: 3021275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal morphine tolerance: use of intrathecal clonidine, DADLE, and intraventricular morphine.
    Coombs DW; Saunders RL; Lachance D; Savage S; Ragnarsson TS; Jensen LE
    Anesthesiology; 1985 Mar; 62(3):358-63. PubMed ID: 3883851
    [No Abstract]   [Full Text] [Related]  

  • 20. Morphine tolerance increases mu-noncompetitive delta binding sites.
    Rothman RB; Danks JA; Jacobson AE; Burke TR; Rice KC; Tortella FC; Holaday JW
    Eur J Pharmacol; 1986 May; 124(1-2):113-9. PubMed ID: 3013657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.